The demo attained both equally its Principal endpoints, with semaglutide two.four mg demonstrating statistically substantial and excellent enhancements in liver fibrosis without any worsening of steatohepatitis, and also resolution of steatohepatitis without worsening of liver fibrosis in individuals with MASH when compared to placebo.oneYour healt